PREVALENCE OF PULMONARY EMBOLISM IN PATIENTS SUFFERING FROM ACUTE EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Main Article Content

Kaleemullah
Mujahid Hussain
Sobia Rehman
Mehreen Umair
Abdul Rehman Azam
Sohail Akhtar

Keywords

Intrahepatic cholestasis of pregnancy, obstetric cholestasis, early-onset ICP, bile acids, preterm delivery, perinatal outcomes

Abstract

Objective: To determine the frequency of pulmonary embolism in patients presented with COPD exacerbations.


Methodology: This cross-sectional study was conducted in Indus Hospital, Karachi, Pakistan from July 2024 to December 2024. A total of 57 patients with COPD exacerbations were analyzed. COPD was defined as: if the ratio of FEVI/FVC was < 0.7 on post-bronchodilator spirometry, then it was considered a case of COPD. Demographic characteristics, vital signs, arterial blood gas, and chest x-ray details were noted. A complete blood count and pulmonary angiography were done to assess the presence of pulmonary embolism.


Results: A total of 57 patients with COPD exacerbation were included and analyzed. The mean age, BMI, and duration of COPD were 63.56±12.06 years, 23.45±23.45 kg/m2, and 17.72±10.31 years. There were 53(93.0%) male, and 4 (7.0%) females. There were 41 (71.9%) patients who belonged to rural areas. History of smoking was present in 55 (96.5%) patients. Seventeen (29.82%) patients were hypertensive, while 3 (5.26%) had diabetes mellitus. Frequency of PE in patient with COPD exacerbation was 8.8% (n=5/57). Relatively higher BMI was associated with the presence of PE (p=0.016).


Conclusion: The prevalence of pulmonary embolism was notable in patients with COPD exacerbations. Pulmonary embolism should be taken more seriously, especially when chest discomfort is present and no obvious infectious cause can be found.

Abstract 0 | Pdf Downloads 0

References

1. Williamson C, Geenes V. Intrahepatic cholestasis of pregnancy. Obstet Gynecol. 2014;124(1):120-133. doi:10.1097/AOG.0000000000000346
2. Pusl T, Beuers U. Intrahepatic cholestasis of pregnancy. Orphanet J Rare Dis. 2007;2:26. doi:10.1186/1750-1172-2-26 PMID: 17535422
3. Kremer AE, Wolf K, Ständer S, et al. Mast cells in pruritus: histamine and beyond. Br J Dermatol. 2014;170(3):569-574. doi:10.1111/bjd.12716
4. Geenes V, Williamson C. Intrahepatic cholestasis of pregnancy. World J Gastroenterol. 2009;15(17):2049-2066. doi:10.3748/wjg.15.2049 PMID: 19418576
5. Reyes H, Báez ME, González MC, et al. Selenium, zinc and copper plasma levels in intrahepatic cholestasis of pregnancy, in normal pregnancies and in healthy individuals, in Chile. J Hepatol. 2000;32(4):542-549. doi:10.1016/s0168-8278(00)80210-6 PMID: 10782901
6. Patil S, Hanumantappa MB, Hiremath PB. Prevalence, maternal and fetal outcomes of intrahepatic cholestasis of pregnancy: a study from South India. Int J Reprod Contracept Obstet Gynecol. 2016;5(9):3127-3130. doi:10.18203/2320-1770.ijrcog20163126
7. Dixon PH, Williamson C. The pathophysiology of intrahepatic cholestasis of pregnancy. Clin Res Hepatol Gastroenterol. 2016;40(2):141-153. doi:10.1016/j.clinre.2015.12.008 PMID: 26823041
8. Bacq Y, Sentilhes L, Reyes HB, et al. Efficacy of ursodeoxycholic acid in treating intrahepatic cholestasis of pregnancy: a meta-analysis. Gastroenterology. 2012;143(6):1492-1501. doi:10.1053/j.gastro.2012.08.004 PMID: 22879390
9. Gorelik J, Shevchuk AI, de Swiet M, et al. Comparison of the arrhythmogenic effects of tauro- and glycoconjugates of cholic acid in an in vitro study of rat cardiomyocytes. BJOG. 2004;111(8):867-870. doi:10.1111/j.1471-0528.2004.00176.x PMID: 15270940
10. Martineau M, Raker C, Powrie R, Williamson C. Intrahepatic cholestasis of pregnancy is associated with an increased risk of gestational diabetes. Eur J Obstet Gynecol Reprod Biol. 2014;176:80-85. doi:10.1016/j.ejogrb.2013.12.037 PMID: 24462219
11. Glantz A, Marschall HU, Mattsson LA. Intrahepatic cholestasis of pregnancy: relationships between bile acid levels and fetal complication rates. Hepatology. 2004;40(2):467-474. doi:10.1002/hep.20336 PMID: 15368452
12. Marathe JA, Lim WH, Metz MP, et al. A retrospective cohort review of intrahepatic cholestasis of pregnancy in a South Australian population. Eur J Obstet Gynecol Reprod Biol. 2017;218:33-38. doi:10.1016/j.ejogrb.2017.09.012 PMID: 28942147
13. Estiú MC, Frailuna MA, Otero C, et al. Relationship between early onset severe intrahepatic cholestasis of pregnancy and higher risk of meconium-stained fluid. PLoS One. 2017;12(4):e0176504. doi:10.1371/journal.pone.0176504 PMID: 28441447
14. Ovadia C, Seed PT, Sklavounos A, et al. Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses. Lancet. 2019;393(10174):899-909. doi:10.1016/S0140-6736(18)31877-4 PMID: 30773280
15. Geenes V, Chappell LC, Seed PT, et al. Association of severe intrahepatic cholestasis of pregnancy with adverse pregnancy outcomes: a prospective population-based case-control study. Hepatology. 2014;59(4):1482-1491. doi:10.1002/hep.26617 PMID: 23857305
16. Dixon PH, Wadsworth CA, Chambers J, et al. A comprehensive analysis of common genetic variation around six candidate loci for intrahepatic cholestasis of pregnancy. Am J Gastroenterol. 2014;109(1):76-84. doi:10.1038/ajg.2013.406 PMID: 24366236
17. Brouwers L, Koster MP, Page-Christiaens GC, et al. Intrahepatic cholestasis of pregnancy: maternal and fetal outcomes associated with elevated bile acid levels. Am J Obstet Gynecol. 2015;212(1):100.e1-7. doi:10.1016/j.ajog.2014.07.026 PMID: 25046808
18. Royal College of Obstetricians and Gynaecologists. Obstetric Cholestasis. Green-top Guideline No. 43. London: RCOG; 2011. Available from: https://www.rcog.org.uk/guidance/browse-all-guidance/green-top-guidelines/.

Most read articles by the same author(s)